Viewing Study NCT00445302


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
Study NCT ID: NCT00445302
Status: COMPLETED
Last Update Posted: 2014-03-13
First Post: 2007-03-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment
Sponsor: Genzyme, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01
Start Date Type: None
Primary Completion Date: 2007-08
Primary Completion Date Type: ACTUAL
Completion Date: 2007-08
Completion Date Type: ACTUAL
First Submit Date: 2007-03-07
First Submit QC Date: None
Study First Post Date: 2007-03-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-12-12
Results First Submit QC Date: None
Results First Post Date: 2011-01-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-02-10
Last Update Post Date: 2014-03-13
Last Update Post Date Type: ESTIMATED